California-based healthcare services and information technology firm McKesson Corp. (MCK) Monday said it has signed a definitive agreement to acquire US Oncology for about $2.16 billion in cash in order to expand its offerings for cancer patients.
Excluding transaction and integration costs, the acquisition is expected to be neutral to McKesson's diluted earnings per share in current fiscal year and modestly accretive beginning fiscal year 2012. The transaction is expected to close by the end of McKesson's third quarter. The combined McKesson Specialty Care Solutions business is expected to help community oncologists to improve care experience for patients and drive business and clinical innovations that address the increasing demand for high-quality, cost-effective, personalized cancer care.
The transaction include the assumption of US Oncology's outstanding debt expecting to be repaid or refinanced. The debt include Senior Floating Rate PIK Toggle Notes due 2012 issued by US Oncology Holdings, Inc., and 9.125% Senior Secured Notes due 2017 and 10.75% Senior Subordinated Notes due 2014, both issued by US Oncology, Inc. The combination will provide oncology customers expanded clinical expertise, clinical research and personalized medicine offerings, integrated, efficiency-enabling healthcare information technology, including the iKnowMed and Lynx technology platforms. The combined company will be led by Bruce Broussard, chairman and chief executive officer of US Oncology, and will be headquartered in Woodlands, Texas, with continuing operations in the San Francisco Bay Area and other locations throughout the country. Broussard will report to Paul Julian, executive vice president and group president, McKesson Corp. In addition, McKesson will continue to operate the United Network of US Oncology, including US Oncology's Comprehensive Strategic Alliance offering, US Oncology Research and other services under the US Oncology brand name. MCK closed Friday's regular trading at $65.98 on the NYSE.
For comments and feedback contact: editorial@rttnews.com
April 10, 2026 16:21 ET Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.